Table 1. Patient Characteristics.
| Variable | Value (n = 120) | |
|---|---|---|
| Age, years | 49.1 ± 12.6 (20–73) | |
| Sex | ||
| Male | 75 (62.5) | |
| Female | 45 (37.5) | |
| BMI, kg/m2 | 26.1 ± 3.5 (18.1–37.2) | |
| Skin-to-liver capsule distance, mm | 19.2 ± 3.9 (11–36) | |
| Aspartate aminotransferase, IU/L | 37.3 ± 34.6 (12–258) | |
| Alanine aminotransferase, IU/L | 45.5 ± 42.0 (9–313) | |
| Hepatic fibrosis grades | ||
| < F2 (without significant fibrosis) | 106 (88.3) | |
| ≥ F2 (with significant fibrosis) | 14 (11.7) | |
| Visual hepatic steatosis grade | ||
| S0 | 49 (40.8) | |
| S1 | 28 (23.3) | |
| S2 | 30 (25.0) | |
| S3 | 13 (10.8) | |
| MRI-PDFF, % | 10.2 ± 7.1 (1–37.7) | |
| < 5 | 38 (31.7) | |
| ≥ 5 to < 10 | 23 (19.2) | |
| ≥ 10 | 59 (49.2) | |
Values are presented as mean ± standard deviation (range) or number (%) as appropriate. BMI = body mass index, MRI-PDFF = magnetic resonance imaging proton density fat fraction